Evidence map›Paper›PMID 31671623›Full record

ArticleMolecules (Basel, Switzerland)2019

Anti-Inflammatory Effects of Formononetin 7-

Min-Seon Kim, Jin-Soo Park, You Chul Chung, Sungchan Jang, Chang-Gu Hyun, Seung-Young Kim

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Anti-Inflammatory Effects ofPharmaceutics · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Prunetin 4'-Molecules (Basel, Switzerland) · 2021
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Min-Seon KimDepartment of Pharmaceutical Engineering & Biotechnology, Sunmoon University, Chungnam 31460, Korea. nari7040@gmail.com.
Jin-Soo ParkNatural Product Informatics Research Center, KIST Gangneung Institute of Natural Products, Korea Institute of Science and Technology (KIST), 679, Saimdang-ro 25451, Korea. jinsoopark@kist.re.kr.ORCID 0000-0001-7349-9808
You Chul ChungDepartment of Chemistry and Cosmetics, Jeju National University, Jeju 63243, Korea. jyc8385@hanmail.net.
Sungchan JangDepartment of Pharmaceutical Engineering & Biotechnology, Sunmoon University, Chungnam 31460, Korea. biochem1004@gmail.com.
Chang-Gu HyunDepartment of Chemistry and Cosmetics, Jeju National University, Jeju 63243, Korea. cghyun@jejunu.ac.kr.
Seung-Young KimDepartment of Pharmaceutical Engineering & Biotechnology, Sunmoon University, Chungnam 31460, Korea. sykim01@sunmoon.ac.kr.
Sun Moon University · KRJeju National University · KRKorea Institute of Science and Technology · KR

Funding

Ministry of Science, ICT and Future Planning 2017R1C1B5018228
6 · The paper itself

Abstract

Biorenovation is a microbial enzyme-catalyzed structural modification of organic compounds with the potential benefits of reduced toxicity and improved biological properties relative to their precursor compounds. In this study, we synthesized a novel compound verified as formononetin 7-

Indexed as

AnimalsAnti-Inflammatory AgentsCell SurvivalCyclooxygenase 2CytokinesDinoprostoneInflammation MediatorsIsoflavonesLipopolysaccharidesMacrophagesMAP Kinase Signaling SystemMiceNF-kappa BNitric OxideNitric Oxide Synthase Type IIRAW 264.7 CellsAnti-Inflammatory AgentsCyclooxygenase 2CytokinesDinoprostoneformononetinInflammation MediatorsIsoflavonesLipopolysaccharidesNF-kappa BNitric OxideNitric Oxide Synthase Type IIRNA, Messengeranti-inflammatorybiorenovationformononetin 7-O-phosphateMAPK pathwayNF-κB pathway

Identifiers

PMID31671623
PMCPMC6864718
OpenAlexW2982307730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.